Position in CATX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$12,440,533
+$135,599 QoQ
Shares Held
2,983,342
-33.3% QoQ
Ownership
2.62%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $12,916,409,991 across 120 Medical Devices names. CATX ranks #43 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
30,101,596 | $3,090,530,851 | |
| 2 | SYK |
Stryker Corp
|
6,297,555 | $2,069,313,587 | |
| 3 | MDT |
Medtronic plc
|
20,717,029 | $1,795,130,554 | |
| 4 | BSX |
Boston Scientific Corp
|
22,266,664 | $1,397,233,160 | |
| 5 | STE |
STERIS plc
|
4,394,263 | $971,703,367 | |
| 6 | EW |
Edwards Lifesciences Corp
|
7,060,876 | $565,434,940 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
6,641,123 | $472,715,127 | |
| 8 | DXCM |
Dexcom Inc
|
5,042,044 | $316,640,357 |
All Filings in CATX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,440,533 | 2,983,342 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $12,304,934 | 4,474,522 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $9,469,750 | 2,760,861 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $5,584,451 | 1,623,388 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $3,319,498 | 1,558,451 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,647,642 | 1,143,462 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $3,810,100 | 285,401 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $1,514,400 | 151,896 | Shares | Defined | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||